BJ Druker, S Tamura, E Buchdunger, S Ohno… - Nature medicine, 1996 - nature.com
The bcr–abl oncogene, present in 95% of patients with chronic myelogenous leukemia
(CML), has been implicated as the cause of this disease. A compound, designed to inhibit …